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Computer-Aided Detection of Metastatic Brain
Tumors Using Automated Three-Dimensional
Template Matching
Robert D. Ambrosini, PhD,1 Peng Wang, PhD,2 and Walter G. O’Dell, PhD3*
Purpose: To demonstrate the efficacy of an automated
three-dimensional (3D) template matching-based algo-
rithm in detecting brain metastases on conventional MR
scans and the potential of our algorithm to be developed
into a computer-aided detection tool that will allow radiol-
ogists to maintain a high level of detection sensitivity
while reducing image reading time.
Materials and Methods: Spherical tumor appearance
models were created to match the expected geometry of
brain metastases while accounting for partial volume
effects and offsets due to the cut of MRI sampling planes.
A 3D normalized cross-correlation coefficient was calcu-
lated between the brain volume and spherical templates
of varying radii using a fast frequency domain algorithm
to identify likely positions of brain metastases.
Results: Algorithm parameters were optimized on training
datasets, and then data were collected on 22 patient data-
sets containing 79 total brain metastases producing a
sensitivity of 89.9% with a false positive rate of 0.22 per
image slice when restricted to the brain mass.
Conclusion: Study results demonstrate that the 3D
template matching-based method can be an effective,
fast, and accurate approach that could serve as a useful
tool for assisting radiologists in providing earlier and
more definitive diagnoses of metastases within the brain.
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AT LEAST ONE brain metastasis will develop in an esti-
mated 100,000 to 200,000 patients out of the more
than 1 million people who are diagnosed with cancer
each year in the United States (1,2). Considerable mor-
tality and morbidity can arise from the presence of
brain metastases with patients most commonly pre-
senting with headaches, seizures, or other neurological
symptoms. However, a significant number of brain me-
tastases are asymptomatic, at least initially, leading to
belated detection and treatment and consequently,
poorer prognoses (3,4). The accurate characterization
of brain involvement is a critical factor in both the
aggressive therapy regimens for good prognosis
patients and the palliative control efforts directed at
the brain metastases patients with terminal systemic
disease (5). Numerous studies have demonstrated that
enhanced quality of life and prolonged survival are
readily attainable goals in many patients when given a
proper and timely diagnosis (6–11). As a result, regular
brain metastasis screenings for patients with extracra-
nial primary tumors must be performed to ensure
appropriate treatment for all patients.
The attractiveness of magnetic resonance imaging
(MRI) as a screening method stems heavily from its
noninvasive nature and lack of known toxicity to
patients, regardless of frequency of exposure, except
for the rare occurrence of gadolinium-associated
nephrogenic systemic fibrosis (NSF) seen only in
patients with renal failure (12,13). In addition, MRI
has been shown to be more sensitive in the detection
of multiple brain metastases when compared directly
with CT scanning (14,15). This ability of MR screening
to identify asymptomatic brain metastases has made
it an important component of the staging process for
newly diagnosed cancer patients (16,17). Yet, com-
pletely manual image reading predisposes to an
increased tendency for reading errors, especially for
small nodules, due to the limitations of 2D image
viewing, user subjectivity, and the demanding work-
load caused by the large number of images produced
by high-resolution volumetric MR imaging (18). A
brain metastasis computer detection algorithm
designed to assist radiologists can counter these
issues through its consistency, reduction of user bias,
and capacity to consider simultaneously the full 3D
tumor information.
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The majority of existing medical imaging automated
detection algorithms can be classified as either being
primarily intensity-based or model-based. Intensity-
based approaches are centered around thresholding
operations and intensity histogram analysis relying
upon the target lesion being consistently brighter (or
possibly darker) than the encompassing normal tissue.
The chief limitation of strictly intensity-based algo-
rithms is that they lack the means to discard any non-
lesion areas of the normal anatomy that also share the
same general intensity profile, which is especially prob-
lematic in MR images where intensity inhomogeneities
and artifacts affect the absolute voxel intensity values.
In general, model-based approaches focus on using
shape or appearance models that are designed to repre-
sent the expected morphology of the target object to
match potentially suspicious regions within images.
While 2D models have been implemented for object
matching (19,20), their lack of capacity to consider 3D
imaging information makes them a less specific and
less desirable option for automated detection. In the
process of constructing a model, feature-based analy-
sis may be used where up to dozens of features are
extracted from identified target lesions during an
extensive training phase and then prioritized for use
based on the quantitative correlation between their
presence and the likelihood of the corresponding image
area being a region of interest. One notable issue with
expanded feature-based analysis methods is that there
is a considerable risk of dependence on too many pa-
rameters and over-training leading to a loss of general-
izability to lesions beyond the used lesion training
dataset. The ideal strategy is to use the minimum num-
ber of features that describe adequately your target
without also applying to other nontarget areas. For this
reason, we have selected an approach dependent only
upon the three most direct descriptors of brain metas-
tases in contrast-enhanced MR brain scans: spherical
or pseudospherical 3D shape, a brighter core than pe-
riphery, and distinct borders from the surrounding
normal brain tissue.
While computer-aided detection (CAD) approaches
have been applied to tumor evaluation in breast and
prostate MR images (21–25), the literature lacks any
brain MR CAD for metastatic tumor detection. In this
study, we present the application of our 3D template
matching-based nodule detection algorithm to clinical
MR brain scans with the goal of identifying a high per-
centage of all metastatic brain tumors while introducing
a reasonably small number of false positives into the final
results. The purpose of this study is to illustrate that,
through the optimization of our algorithm for MR brain
screening, we will be able to offer a CAD tool for meta-
static brain tumors that will address issues of accuracy
and efficiency by providing radiologists with locations of
high suspicion for nodule presence.
MATERIALS AND METHODS
Patient MR Datasets
The tumor detection operations for this research
were conducted entirely upon patient MR scans that
had been accumulated previously at our institution.
This patient medical image-centered study was
approved by our institution’s review board and was
compliant with the Health Insurance Portability and
Accountability Act (HIPAA). All anatomical MR scans
that were used for metastasis detection were col-
lected with a 1.5 Tesla (T) GE Genesis Signa scanner
and have an in-plane resolution of 0.43 mm and a
slice thickness and separation of 2.5 mm. These T1-
weighted postcontrast images were obtained using a
spoiled gradient echo pulse sequence (SPGR) with
TR/TE ¼ 14/3 ms, flip angle ¼ 30, 512  512 ma-
trix, and field of view (FOV) ¼ 220 mm. In this
study, nine patient datasets consisting of 540 coro-
nal MR slices designated as training datasets and 22
patient datasets consisting of 1320 coronal MR slices
assigned as testing datasets were processed using
our detection algorithm. A total of 124 brain metas-
tases were present within the training datasets rang-
ing in diameter from 2 to 26 mm (median ¼ 7 mm),
where the median number of metastatic tumors per
dataset was 12 with one dataset containing zero
metastases. A total of 79 brain metastases were
present within the testing datasets ranging in diame-
ter from 3 to 45 mm (median ¼ 7 mm) where the
median number of metastatic tumors per dataset
was 3 with one dataset containing zero metastases.
The presence and location of brain metastases were
confirmed by follow-up examination, listing in
the radiologist clinical report, and when necessary,
independent radiologist reading at the authors’
institution.
Brain Dataset Extraction and Preprocessing
Semi-automated extraction was performed on each
patient dataset before it being subjected to the detec-
tion component of the algorithm so as to increase
computation speed. An interactive method for skull-
stripping was selected rather than a fully automated
approach to ensure consistency in anatomical voxels
present among processed datasets and to guarantee
that study results were dependent only upon the per-
formance of our detection algorithm and not on the
quality of the brain extraction. An active contour
(snake) modified by our lab to incorporate 3D image
slice data for control point and curve initialization
was used as our means of separating the brain mass
from the skull and other nonbrain soft tissue (26).
The utilized snake implementation used cubic Her-
mite spline interpolation where user interaction
involved the ability to adjust control point location
and slope as necessary. Snake placement was setup
to achieve the simplest contouring of the brain mass
where the ventricles, the dural venous sinuses at the
brain’s surface, and the branches of the internal ca-
rotid arteries adjacent to the brain were not excluded.
On average, semi-automated brain extraction required
less than 20 min per MR dataset (60 coronal slices).
Preprocessing of datasets to correct for MR intensity
artifacts and inhomogeneities was not performed for
this study.
86 Ambrosini et al.
Spherical Template Appearance
Model Construction
Brain metastases have been described as spherical or
spheroid structures that are well-circumscribed in
appearance on contrast-enhancing MR brain scans as
a result of clear margins with surrounding anatomical
tissue (16,27). Our algorithm uses these typical fea-
tures of brain metastasis morphology through the use
of a 3D spherical template that incorporates a zero
padding parameter to account for the well-demarcated
nature of metastasis borders (28). Zero padding refers
to the inclusion of a uniform number of zero intensity
values around the border of the high-intensity
spherical template. Both in-plane and slice thickness
direction partial volume effects were included in the
generation of these models so as to match more accu-
rately the voxel representation of a 3D nodule in MR
imaging. Specifically, three different spatial models
were used for each size 3D template to compensate
for the partial volume effects seen in the slice thick-
ness direction. One spatial model placed the central
MR cut-plane exactly through the center of the spheri-
cal template while the other two models offset the cen-
ter of the sphere from the central cut-plane in equal
and opposite directions by one-third the slice thick-
ness (Fig. 1). A complete template included a zero
padding slice both before and after spherical template
slices.
Template Matching Parameters
For the optimal balance between the algorithm’s sen-
sitivity and the false positive rate, the threshold value
for our similarity metric, the normalized cross-correla-
tion coefficient (NCCC), and the appropriate size for
the zero padding can be selected on the basis of the
results from a set of patient images. Formal training
datasets were used for this objective and then the
optimal NCCC threshold value and zero padding size
were applied to a separate group of testing datasets
so as to ensure the generalizability of the algorithm
results. Twelve 3D spherical templates were applied
to each MR dataset with radii ranging at evenly
spaced intervals from four times to twenty times the
in-plane voxel size. Preliminary empirical results had
demonstrated that this range of template sizes would
provide a sufficient capture range for clinically rele-
vant tumors where CAD would be most beneficial. In
our nodule detection approach, an individual NCCC
value was computed for each specific spherical tem-
plate, defined by its unique combination of radius
and spatial orientation, at every voxel within each
processed MR dataset. This was accomplished by
aligning iteratively the center voxel of each spherical
template with each voxel of the MR dataset until an
NCCC value had been calculated throughout the
entire 3D image volume. The processing time for an
average 60 slice extracted dataset was approximately
30 min running in The MathWorks, Inc.’s MATLAB
7.2 on a Power Mac G5 with quad 2.5 GHz processors
and 4 gigabytes of RAM. Only the 11 largest templates
were used when the algorithm was directed to target
nodules with a manually measured diameter greater




A normalized cross-correlation coefficient (NCCC) was
used to identify the degree of similarity between the
3D regions of the image and spherical templates of
varying radii. The NCCC was selected as the similarity
metric as it allows for 3D feature matching that is not
dependent on the absolute voxel intensity values, alle-
viating concerns over brightness variations that can
occur among MR datasets due to different scanning
parameters and intensity inhomogeneities. To reduce
computational cost, the calculation of the NCCC was
performed in the Fourier domain of the MR image
region and the spherical template using a 3D exten-
sion of Lewis’ approach (29):
NCCCðu;v;wÞ
¼ Rx ;y;z ½f ðx ;y;zÞ f u;v;w  ½tðxu;yv;zwÞ tffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Rx ;y;z ½f ðx ;y;zÞ f u;v;w2 Rx ;y;z ½tðxu;yv;zwÞ t2
q
where t is the template, f is the image, t is the mean
of the template, f u;v;w is the mean of the image region
under the template, and summations are performed
over x,y,z under the window containing the template
positioned at u,v,w. The NCCC can produce a range of
values from 1 to þ1 depending upon the similarity
of the analyzed image regions where a value of þ1
indicates an exact matching of the image regions, a
value of 1 indicates an exact matching of the inverse
of one image region with the other image region, and
a value of zero indicates no correlation. Only image
coordinates that generated an NCCC value above an
experimentally determined threshold were identified
Figure 1. Models illustrating the variations in appearance of
a 10-mm diameter sphere on simulated MR image slices
caused by changes in position of the central image cut-plane.
The 3D spherical objects and image cut-planes are shown
above where image slices are 2.5 mm thick, while the corre-
sponding appearance of the sphere on simulated image slices
is shown below with 0.43  0.43 mm in-plane voxel dimen-
sions. Left pair: central cut-plane intersecting exact center of
sphere. Right pair: central cut-plane shifted one-third of the
slice thickness from the exact center of sphere.
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as locations of potential brain metastases. Redundant
detections were removed by grouping all image points
connected in 3D that provided an above-threshold
NCCC value. A detection was considered a true posi-
tive if the voxel with the highest NCCC value within a
group of connected above-threshold image points
overlapped with the contrast-enhancing voxels of an
identified brain metastasis. All other detections were
labeled as false positives.
Nodule Stratification and False Positive Analysis
Nodules in the testing datasets were stratified with
regard to diameter and MR appearance characteristics
to establish patterns in false negatives produced by the
algorithm results. Ring-enhancing nodules were classi-
fied as ‘‘Hollow,’’ nodules compressed at any exterior or
interior anatomical surface of the brain were classified
as ‘‘Edge,’’ nodules that have their full 3D shape cut off
by either the first or last slice of the MR dataset were
classified as ‘‘Partial,’’ and nodules within patient
brains that were treated with radiation therapy before
MR scan acquisition were classified as ‘‘Radiated.’’ Sim-
ilarly, false positives found within the results for the
testing datasets were analyzed for patterns in image
location. Specifically, the number of false positives
found within the dural venous sinuses at the exterior
surface of the brain mass and false positives found
within the internal carotid artery branches adjacent to
the brain mass were tabulated to determine the per-
centage of false positives provided by the MR represen-




The major underlying hypothesis for our tumor detec-
tion algorithm is that a 3D spherical template sur-
rounded with a uniform layer of zero padding will cor-
relate highly with the typical patterns of brain
metastases on MR datasets. Normal anatomical struc-
tures such as cerebral blood vessels should be
avoided as false positives in our final detection results
due to poor matching of their 3D branching with the
zero padding parameter. Figure 2 demonstrates the
marked 3D correlation that can be achieved between
brain metastases and a spherical template of the




An important component of our tumor detection ef-
forts is determining the most effective zero padding
size and NCCC threshold value to achieve consistently
a high level of specificity for metastasis detection. Fig-
ure 3a illustrates the effects of changing the amount
of zero padding that uniformly surrounds each spheri-
cal template on the overall accuracy of the detection
process for one patient’s dataset (total of 10 lesions).
The same patient’s dataset was then used to produce
Figure 3b which demonstrates the relationship
between the efficacy of the detection method and the
Figure 2. a,b: MR coronal
image slices of extracted pa-
tient’s brain where locations of
known metastases are indicated
by circle. c,d: Correlation maps
at corresponding slice locations
in patient image set where the
gray-level values represent the
3D normalized cross-correlation
coefficient (NCCC) at each voxel
between a 3D spherical template
and the 3D patient image data-
set. Correlation map shown in (c)
corresponds to MR image slice
shown in (a), and correlation
map shown in (d) corresponds to
MR image slice shown in (b).
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NCCC threshold that must be exceeded between a
pixel and the spherical template for that spatial posi-
tion to be considered a metastasis candidate. These
two figures exhibit the need to find the optimal set-
tings for both zero padding size and the NCCC thresh-
old value due to the fact that increasing the value of
either parameter reduces substantially the number of
false positives while at the same time increasing the
risk that a true positive will be missed.
To establish the optimal settings for our template
matching approach, a total of nine patient datasets
(540 total coronal MR slices) were processed by our
algorithm using 25 different combinations of zero
padding size and NCCC threshold value. Figure 4 vis-
ualizes this effect of varying the zero padding size and
NCCC threshold value on the efficacy of our detection
algorithm by providing the relationship between the
sensitivity and the number of false positives per MR
slice as the two parameters are adjusted. This figure
indicates that the optimal balance between sensitivity
and false positive rate for these nine datasets was
achieved at a zero padding size of 0.86 mm and a
NCCC threshold equal to 0.525 where the overall sen-
sitivity was 87.1% (108 of 124 nodules detected) and
the false positive rate was 0.62 per image slice.
Algorithm Performance—Testing Datasets
The determined optimal algorithm parameters were
then applied to testing datasets for the purpose of
ascertaining our algorithm’s current level of perform-
ance. Sensitivity equal to 89.9% (71 of 79 nodules
detected) with a false positive rate of 0.58 per image
slice was attained using the zero padding size of
0.86 mm and a NCCC threshold of 0.525. For these
same zero padding size and NCCC threshold values,
the sensitivity remained relatively constant at 90.5%
(57 of 63 nodules detected) while the false positive
rate was reduced to 0.36 per image slice when omit-
ting from consideration nodules less than two slices
(5 mm) in diameter.
Figure 3. Detection algorithm results for MR coronal dataset (voxel size ¼ 0.43  0.43  2.5 mm) of a single patient’s brain
with 10 radiologist-documented metastases. a: The sensitivity and false positive values were produced by combining each
padding size with a range of spherical template diameters (3.44, 4.30, 5.16, 6.02, 6.88, and 7.74 mm) and then pooling the
metastasis candidate data generated by the six different sized templates that had the same amount of padding. A metastasis
candidate position was considered a true positive if it corresponded spatially to one of the metastases identified by the radiol-
ogist, while other candidate positions were labeled as false positives. In all cases, a normalized cross-correlation coefficient
(NCCC) value greater than or equal to 0.5 was used to identify metastasis candidate locations produced by the template
matching. b: Same process as in (a), except the template padding size was held at a constant value (1.29 mm) and the metas-
tasis candidate data was pooled according to the NCCC threshold value that was used to indicate a matched position for
each range of template sizes.
Figure 4. Detection algorithm results combined from nine
training patient datasets (540 coronal MR slices with voxel
size ¼ 0.43  0.43  2.5 mm) containing 124 total brain
nodules. Each of the 25 data points represent the sensitivity
and number of false positives per image slice produced at
one combination of zero padding size and normalized cross-
correlation coefficient (NCCC) threshold value. NCCC thresh-
old values of 0.550, 0.525, 0.500, 0.475, and 0.450 corre-
spond to the first, second, third, fourth, and fifth points from
left to right on each line of zero padding size, respectively.
The arrow indicates selected optimal parameters based on
these curves.
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Sources of False Positives
Figure 5 shows MR image examples of the dural
venous sinuses and branches of the internal carotid
arteries where artifacts of brain extraction or typical
variations in MR image quality can lead to these blood
vessels having a roughly spherical MR image appear-
ance. An examination of our 22 processed testing
datasets revealed that on average 43.7% (68.9%) of
the produced false positives were found in some
region of the dural venous sinuses and 18.0%
(68.3%) of the false positives were located within the
branches of the internal carotid artery (Table 1). Con-
sequently, this leads to our algorithm having a false
positive rate of 0.22 per image slice (sensitivity ¼
89.9%) for the full range of nodule diameters when
analysis is restricted to the brain mass only, exclud-
ing the areas of the dural venous sinuses and internal
carotid artery branches along the brain’s border. A
false positive rate of 0.12 per image slice (sensitivity ¼
90.5%) is achieved when both analysis is restricted to
the brain mass and nodules less than two slices
(5 mm) in diameter are omitted from consideration.
Stratification of Detection Sensitivity Results by
Nodule Characteristics and Size
Another noteworthy point of evaluation for our algo-
rithm is its applicability to brain metastases that devi-
ate from the classic patterns of contrast-enhancement
or 3D morphology represented by our templates. The
MR intensity profile of certain nodules may appear to
be hollow (ring-enhancing) as a result of their necrotic
cores. Brain metastases may deviate from strictly
Figure 5. Common positions of
false positives found by our algo-
rithm. a: MR image slice showing
the dural venous sinuses. b: MR
image slice showing the branches
of the internal carotid arteries.
Table 1
Proportion of False Positives Located Within the Dural Venous Sinuses and the Internal Carotid Arteries and Its Branches*
Total
Dural venous sinuses Internal carotid artery
Dataset # of FPs # of FPs % of Total # of FPs % of Total
1 38 18 47.4 9 23.7
2 38 13 34.2 10 26.3
3 30 15 50.0 4 13.3
4 37 16 43.2 10 27.0
5 20 6 30.0 7 35.0
6 30 15 50.0 4 13.3
7 34 16 47.1 6 17.6
8 67 33 49.3 8 11.9
9 41 17 41.5 10 24.4
10 27 12 44.4 4 14.8
11 23 9 39.1 0 0.0
12 32 17 53.1 6 18.8
13 16 6 37.5 3 18.8
14 25 13 52.0 5 20.0
15 29 11 37.9 5 17.2
16 22 6 27.3 5 22.7
17 30 14 46.7 6 20.0
18 55 27 49.1 9 16.4
19 16 4 25.0 5 31.3
20 42 25 59.5 3 7.1
21 66 29 43.9 4 6.1
22 47 25 53.2 5 10.6
Total 765 347 43.7 (68.9) 128 18.0 (68.3)
*FPs, false positives.
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spherical geometry due to compression from their
growth in locations adjacent to either the brain’s exte-
rior surface or medial anatomical structures. The
nodule being located within the brain such that its
full 3D structure is clipped off in either the first or
last slice of the image set can cause the same effect
on a metastasis’ appearance in an MR dataset. In
addition, the ability to detect accurately both metasta-
ses that have been irradiated and untreated nodules
is critical for the chief clinical applications that may
be served by our algorithm. Table 2 shows the effects
of these different metastasis characteristics on our
algorithm’s detection sensitivity where each column
presents the sensitivity results for only nodules within
the given category and then all nodules except
those that are within the given category. Furthermore,
Table 3 demonstrates the accuracy of our approach
when applied to varying ranges of metastasis diameter
where each column presents the sensitivity results for
only nodules below the given diameter and then all
nodules except those below the given diameter. The
data presented in these tables demonstrate the
general robustness of our standard 3D template
matching-based detection algorithm with regard to
variations in metastasis morphology, intensity profile,
and size.
DISCUSSION
In this study, we have presented our automated
approach applied specifically for the detection of me-
tastases on brain MR scans. The basis for our algo-
rithm is 3D template matching between MR image fea-
tures and 3D spherical tumor appearance models
constructed to represent typical geometrical patterns
of brain metastases. At its current optimal settings for
zero padding size and NCCC threshold, our algorithm
achieved a sensitivity of 89.9% with 0.58 false posi-
tives per slice when applied to coronal MR datasets
containing metastases ranging in diameter from 3 to
45 mm. These values are extremely similar to the sen-
sitivity (87.1%) and false positive rate (0.62 per image
slice) found for the training datasets at the same
algorithm parameters and, thus, indicate a presumed
representative nature of the results. Due to a lack of
data in the literature regarding automatic detection of
MR brain lesions, we are unable to compare our
results with a pre-existing standard. Nevertheless,
these results are extremely encouraging as they repre-
sent a high detection rate and a manageable number of
false positives without any restrictions having been
placed on target nodules with regard to size, heteroge-
neity, or whether a metastasis’ morphology has been
altered by treatment with radiation before the patient’s
scanning. When restricting our algorithm to detecting
only nodules with a measured diameter greater than or
equal to twice the slice thickness (diameter greater than
or equal to 5 mm), our sensitivity can be maintained
relatively constant at 90.5% while our false positive rate
drops to 0.36 per image slice.
Another positive aspect of these results is that there
are clearly identifiable patterns for our approach with
regard to the sources of false positive readings. The
fact that greater than 60% of our false positives stem
from either the dural venous sinuses or the branches
of the internal carotid arteries indicates that the
incorporation of anatomical model-based information
into our extraction methods will lead to the elimina-
tion of the majority of our false positives. Recently, an
automatic brain extraction approach has been pre-
sented that has shown the ability to remove the dural
venous sinuses and branches of the internal carotid
arteries while preserving brain metastasis morphology
(30). The substantial reduction in false positive rate
that would be provided by the automatic extraction of
the dural venous sinuses and branches of the internal
carotid arteries would enable the utilization of less
stringent algorithm parameters (zero padding size and
NCCC threshold), leading to an additional rise in
detection sensitivity (data not shown). Similarly, the
relatively predictable 3D morphology and intensity
profiles of the dural venous sinuses and branches of
the internal carotid arteries suggest that direct detec-
tion of these false positive sources through template
matching, filtering, or another similar preprocessing
technique may prove to be an alternative and equally
efficacious means of achieving improved tumor detec-
tion algorithm performance (31). Furthermore, human
readers would dismiss easily false positives found
Table 2
Detection Algorithm Sensitivity for Brain Metastases Stratified by Nodule Characteristics
Sensitivity (%)
Hollow Edge Partial Radiated
Only 85.7 (24/28) 80.0 (12/15) 80.0 (4/5) 96.3 (26/27)
Excluding 92.2 (47/51) 92.2 (59/64) 90.5 (67/74) 86.5 (45/52)
Table 3
Detection Algorithm Sensitivity for Brain Metastases Stratified by Nodule Diameter
Sensitivity (%)
<5 mm <8 mm <11 mm <14 mm
Only 87.5 (14/16) 90.0 (36/40) 87.3 (48/55) 88.1 (52/59)
Excluding 90.5 (57/63) 89.7 (35/39) 95.8 (23/24) 95.0 (19/20)
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within normal anatomical structures outside the
brain and this notion reinforces our algorithm’s
potential as a radiologist CAD tool in its current form.
As it stands now, the restriction of analysis only to
areas within the brain mass reduces the false positive
rate to 0.22 per image slice (sensitivity ¼ 89.9%) for
the full range of nodule sizes while the false positive
rate is 0.12 per image slice (sensitivity ¼ 90.5%) when
the algorithm is also restricted to searching for only
nodules with a diameter greater than twice the MR
slice thickness. These results are comparable to the
better results from CAD algorithms applied to other
organs such as lung (28 and references therein).
The results showing the number of false positives
found within the dural venous sinuses and the
branches of the internal carotid arteries also elucidate
the advantage of a 3D template matching-based
approach over simple intensity thresholding. An MR
brain metastasis detection algorithm that relies heav-
ily on intensity thresholding without 3D morphology
consideration will generate false positives throughout
all regions of the dural venous sinuses and internal
carotid artery branches. Our 3D template matching-
based approach provides the general exclusion of the
greater parts of cylindrical structures such as the
brain’s major blood vessels both at the surface of and
enclosed within the brain mass. Under the same prin-
ciple, spherical template matching is also avoiding
many other cerebral sources of false positives that
would be found by algorithms relying strictly on inten-
sity thresholding. The dural venous sinuses, internal
carotid artery branches, and other normal cerebral
structures only appear as false positives with spheri-
cal template matching when inhomogeneities in MR
scan intensities cause regions of these structures to
appear spherical.
The major potential limitation for our algorithm is
the possibility that the brain metastases to be
detected may differ considerably from the hypothe-
sized spherical morphology and intensity profile rep-
resented by our 3D tumor appearance models. We use
MR imaging because it has been shown to be more
sensitive in detecting multiple brain metastases; how-
ever, the presence of scan inhomogeneities and patchy
enhancement with gadolinium contrast may exacer-
bate metastasis heterogeneity. Although our results
indicate that our 3D template matching-based system
can often be effective when applied in these circum-
stances, the goal of achieving a detection sensitivity
more closely approaching 100% necessitates account-
ing for the varied presentations of metastases that
may arise on conventional brain MR scans. For this
purpose, we have begun implementing template modi-
fications that will enable improved matching for me-
tastases that are problematic to detect due to features
such as hollow, necrotic cores and irregular growth
patterns at the brain’s borders. In particular, techni-
ques such as template matching with hollow tem-
plates, the use of a negative NCCC to detect the dark,
spherical cores of ring-enhancing nodules, and the
incorporation of 3D brain morphology data to intro-
duce anatomical border effects into the tumor appear-
ance model construction all have the potential to
allow a further increase in sensitivity while decreasing
the false positive rate at a small additional computa-
tional cost.
In conclusion, the primary objective of this study
was to demonstrate that brain metastases follow con-
sistent and predictable patterns of general 3D mor-
phology and intensity profiles on MRI scans that can
be matched successfully by 3D spherical tumor
appearance models through the use of the NCCC as
an accurate and low computational cost similarity
measure. The most significant practical consequence
of this work was illustrating the feasibility of a 3D
template matching-based approach in forming the
foundation behind a CAD tool that could be used to
assist radiologists in brain metastasis screening.
While our algorithm may not reach or exceed the
capabilities of a trained radiologist, it does achieve
the critical CAD algorithm goal of being complemen-
tary to human reader performance (32). For example,
although our CAD algorithm did produce a false nega-
tive rate equal to 10.1% (8 of 79 nodules not
detected), all eight nodules not detected by our CAD
algorithm had been detected successfully by prior
first-pass manual radiologist reading. In its current
state, our system can reduce the number of spatial
positions that need to be examined from potentially
thousands to less than one per slice in most datasets.
Figure 6. a,b: MR images from
two different patients at our
institution where brain metas-
tases (circled) were missed
during initial radiologist read-
ing of scans without the use of
a computer-aided detection
tool, but detected automati-
cally by our algorithm.
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This CAD tool would serve to alleviate greatly the
workload burden on radiologists by reducing image
reading time as well as meet a previously described
need for an automated system of metastasis target
labeling (5). Moreover, due to the high volume of
scans to be read, reader fatigue, and the complexity
of images, it is inevitable that some small brain me-
tastases are currently being missed without the use of
a computer assist tool, as observed in 2 of the 22 test-
ing datasets (Fig. 6). As a result, the utilization of a
CAD tool would serve to improve not only the effi-
ciency, but also the accuracy of brain metastasis
screening performed on at-risk cancer patients.
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